This inventor holds 1 USPTO granted patent. Top assignees: Chugai Pharmaceutical Co., Sato Pharmaceutical Co., Ltd.. Active years: 1995.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 14 
1 out of 18 Years Active: 1995
Title: Masahide Katayama: Innovator in Pharmaceutical Preparations
Introduction
Masahide Katayama is a notable inventor based in Shinagawa, Japan. He is recognized for his contributions to the field of pharmaceuticals, particularly in the development of liquid preparations that protect mucous membranes.
Latest Patents
Katayama holds a patent for an aqueous suspension of sucralfate. This invention involves a stable aqueous suspension that includes sucralfate, starch, and various derivatives, which can be redispersed as needed. This innovative formulation provides a liquid pharmaceutical preparation that is useful for protecting ulcer areas in the stomach and duodenum, marking a significant advancement over traditional solid preparations.
Career Highlights
Throughout his career, Masahide Katayama has worked with prominent companies in the pharmaceutical industry, including Chugai Pharmaceutical Co. and Sato Pharmaceutical Co., Ltd. His work has contributed to the development of effective treatments for gastrointestinal issues.
Collaborations
Katayama has collaborated with notable colleagues such as Harushige Yamashita and Taizo Okada. Their combined expertise has furthered advancements in pharmaceutical innovations.
Conclusion
Masahide Katayama's contributions to the field of pharmaceuticals, particularly through his patent for an aqueous suspension of sucralfate, highlight his role as an important inventor in the industry. His work continues to impact the development of effective medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile